Global Nuclear Medicine Diagnostics Market Size study, by Type (SPECT radiopharmaceuticals, PET radiopharmaceuticals) Modality (SPECT, PET, Alpha-emitters, Beta-emitters, Brachytherapy) Application (Cardiology, Thyroid, Neurology, Oncology, Others) Procedure (Oncology, Cardiovascular, Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genito-urinary, Pulmonary, others) End User (Hospital and diagnostic centres, and Research institutions) and Regional Forecasts 2021-2027
Global Nuclear Medicine Diagnostics Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. The market is currently expanding due to an increase in the number of cancer cases and increased awareness of nuclear medicine. Radiopharmaceuticals are pharmaceutical formulations that contain radioactive isotopes for diagnostic and therapeutic purposes. They are tiny basic objects that contain a radioactive chemical that is used to treat cancer, as well as cardiac and neurological diseases. For oncology and cancer treatment, traditional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals, which opens up new paths in the radiopharmaceuticals industry. It also serves as a convenient and safer alternative to X-Rays and other external radiation imaging equipment for patients. In applications such as lymphoma and bone metastases, radiopharmaceuticals, often known as nuclear medications, are used. Nuclear medicines such as F-18, Tc-99, Ga-67, and I-123 are used in diagnostic operations, while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223 are employed in therapeutic procedures. Thyroid-related diseases, respiratory diseases, bone diseases, and neurological diseases are among the disorders for which research and studies are undertaken. For instance, in July 2019, French researchers presented data demonstrating the use of hafnium oxide nanoparticle NBTXR3 as a radio enhancer to boost radiation response for soft-tissue sarcoma. PET is a type of radioisotope imaging that employs radioisotopes to diagnose organs. PET is becoming more widely used as a diagnostic tool because it is more accurate than other diagnostic procedures. It is usually combined with X-ray and computed tomography to improve accuracy (CT). The radiopharmaceuticals market is being fueled by a growing demand for rapid and precise diagnosis, as well as a growing demand for better medical solutions. The radiopharmaceuticals market is being fueled by a growing demand for early and precise diagnosis, as well as a demand for better medical solutions. However, radiopharmaceuticals' short half-life hinders their potential adoption, while hospital budget cuts and costly equipment expenses are projected to limit market growth.
The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Nuclear Medicine Diagnostics market. Due to high investments in R&D and government support for the use of medical isotopes, North America dominated the global market in terms of revenue in 2019. In the same year, Europe's market also accounted for a significant portion of the global market. During the forecast period, the Asia Pacific market is expected to increase at a significant rate. The radiopharmaceuticals market in this region is growing due to an increasing elderly population and increased awareness of nuclear treatments and molecular imaging. This region is also concentrating on the development of radiopharmaceuticals for the diagnosis and treatment of a variety of disorders. For instance, In August 2018, the National Nuclear Agency of Indonesia (BATAN) collaborated with the International Atomic Energy Agency (IAEA) to create innovative radiopharmaceuticals (99mTc-ethambutol) for tuberculosis diagnostics.
Major market player included in this report are:
Cardinal Health
GE Healthcare
Curium Pharma
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Nordian
Advanced Accelerator Applications
IBA Molecular Imaging
Mallinckrodt PLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed inRoute of Administrationation about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
PET radiopharmaceuticals SPECT radiopharmaceuticals
By Modality:
SPECT
PET
Alpha-emitters
Beta-emitters
Brachytherapy
By Application:
Cardiology
Thyroid
Neurology
Oncology
Others
By Procedure:
Oncology
Cardiovascular
Central Nervous System
Endocrine
Skeletal
Gastrointestinal
Genito-urinary
Pulmonary
PET & PET-CT
Therapeutic
Others
By End-User:
Hospitals and diagnostic centers
Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Nuclear Medicine Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Nuclear Medicine Diagnostics market. Due to high investments in R&D and government support for the use of medical isotopes, North America dominated the global market in terms of revenue in 2019. In the same year, Europe's market also accounted for a significant portion of the global market. During the forecast period, the Asia Pacific market is expected to increase at a significant rate. The radiopharmaceuticals market in this region is growing due to an increasing elderly population and increased awareness of nuclear treatments and molecular imaging. This region is also concentrating on the development of radiopharmaceuticals for the diagnosis and treatment of a variety of disorders. For instance, In August 2018, the National Nuclear Agency of Indonesia (BATAN) collaborated with the International Atomic Energy Agency (IAEA) to create innovative radiopharmaceuticals (99mTc-ethambutol) for tuberculosis diagnostics.
Major market player included in this report are:
Cardinal Health
GE Healthcare
Curium Pharma
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Nordian
Advanced Accelerator Applications
IBA Molecular Imaging
Mallinckrodt PLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed inRoute of Administrationation about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
PET radiopharmaceuticals SPECT radiopharmaceuticals
By Modality:
SPECT
PET
Alpha-emitters
Beta-emitters
Brachytherapy
By Application:
Cardiology
Thyroid
Neurology
Oncology
Others
By Procedure:
Oncology
Cardiovascular
Central Nervous System
Endocrine
Skeletal
Gastrointestinal
Genito-urinary
Pulmonary
PET & PET-CT
Therapeutic
Others
By End-User:
Hospitals and diagnostic centers
Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Nuclear Medicine Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Nuclear Medicine Diagnostic Market, by Region, 2019-2027 (USD Billion)
1.2.2. Nuclear Medicine Diagnostic Market, by Type, 2019-2027 (USD Billion)
1.2.3. Nuclear Medicine Diagnostic Market, by Modality, 2019-2027 (USD Billion)
1.2.4. Nuclear Medicine Diagnostic Market, by Application, 2019-2027 (USD Billion)
1.2.5. Nuclear Medicine Diagnostic Market, by Procedure, 2019-2027 (USD Billion)
1.2.6. Nuclear Medicine Diagnostic Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET DYNAMICS
3.1. Nuclear Medicine Diagnostic Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising number of new cancer cases
3.1.1.2. Increasing adoption of SPECT and PET modality
3.1.2. Market Challenges
3.1.2.1. Stringent government regulations
3.1.3. Market Opportunities
3.1.3.1. Innovations in neurological applications
CHAPTER 4. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Nuclear Medicine Diagnostic Market by Type, Performance - Potential Analysis
5.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
5.4.1. SPECT radiopharmaceuticals
5.4.2. PET radiopharmaceuticals
CHAPTER 6. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY MODALITY
6.1. Market Snapshot
6.2. Global Nuclear Medicine Diagnostic Market by Modality, Performance - Potential Analysis
6.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Modality 2018-2027 (USD Billion)
6.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
6.4.1. SPECT
6.4.2. PET
6.4.3. Alpha-emitters
6.4.4. Beta-emitters
6.4.5. Brachytherapy
CHAPTER 7. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Nuclear Medicine Diagnostic Market by Application, Performance - Potential Analysis
7.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
7.4.1. Cardiology
7.4.2. Thyroid
7.4.3. Neurology
7.4.4. Oncology
7.4.5. Others
CHAPTER 8. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY PROCEDURE:
8.1. Market Snapshot
8.2. Global Nuclear Medicine Diagnostic Market by Procedure, Performance - Potential Analysis
8.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Procedure 2018-2027 (USD Billion)
8.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
8.4.1. Oncology
8.4.2. Cardiovascular
8.4.3. Central Nervous System
8.4.4. Endocrine
8.4.5. Skeletal
8.4.6. Gastrointestinal
8.4.7. Genito-urinary
8.4.8. Pulmonary
8.4.9. PET & PET-CT
8.4.10. Therapeutics
8.4.11. Others
CHAPTER 9. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY END-USER:
9.1. Market Snapshot
9.2. Global Nuclear Medicine Diagnostic Market by End-User, Performance - Potential Analysis
9.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
9.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
9.4.1. Hospitals and diagnostic centres
9.4.2. Research Institutes
CHAPTER 10. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, REGIONAL ANALYSIS
10.1. Nuclear Medicine Diagnostic Market, Regional Market Snapshot
10.2. North America Nuclear Medicine Diagnostic Market
10.2.1. U.S. Nuclear Medicine Diagnostic Market
10.2.1.1. Type breakdown estimates & forecasts, 2018-2027
10.2.1.2. Modality breakdown estimates & forecasts, 2018-2027
10.2.1.3. Application breakdown estimates & forecasts, 2018-2027
10.2.2. Canada Nuclear Medicine Diagnostic Market
10.3. Europe Nuclear Medicine Diagnostic Market Snapshot
10.3.1. U.K. Nuclear Medicine Diagnostic Market
10.3.2. Germany Nuclear Medicine Diagnostic Market
10.3.3. France Nuclear Medicine Diagnostic Market
10.3.4. Spain Nuclear Medicine Diagnostic Market
10.3.5. Italy Nuclear Medicine Diagnostic Market
10.3.6. Rest of Europe Nuclear Medicine Diagnostic Market
10.4. Asia-Pacific Nuclear Medicine Diagnostic Market Snapshot
10.4.1. China Nuclear Medicine Diagnostic Market
10.4.2. India Nuclear Medicine Diagnostic Market
10.4.3. Japan Nuclear Medicine Diagnostic Market
10.4.4. Australia Nuclear Medicine Diagnostic Market
10.4.5. South Korea Nuclear Medicine Diagnostic Market
10.4.6. Rest of Asia Pacific Nuclear Medicine Diagnostic Market
10.5. Latin America Nuclear Medicine Diagnostic Market Snapshot
10.5.1. Brazil Nuclear Medicine Diagnostic Market
10.5.2. Mexico Nuclear Medicine Diagnostic Market
10.6. Rest of The World Nuclear Medicine Diagnostic Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. AMCS group
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Caverion corporation
11.2.3. Aerbin ApS
11.2.4. MariMatic Oy
11.2.5. Envac Group
11.2.6. Logiwaste AB
11.2.7. AWC Berhad Gropu
11.2.8. Ros Roca SA
11.2.9. Greenwave Solutions
11.2.10. STREAM environment
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Nuclear Medicine Diagnostic Market, by Region, 2019-2027 (USD Billion)
1.2.2. Nuclear Medicine Diagnostic Market, by Type, 2019-2027 (USD Billion)
1.2.3. Nuclear Medicine Diagnostic Market, by Modality, 2019-2027 (USD Billion)
1.2.4. Nuclear Medicine Diagnostic Market, by Application, 2019-2027 (USD Billion)
1.2.5. Nuclear Medicine Diagnostic Market, by Procedure, 2019-2027 (USD Billion)
1.2.6. Nuclear Medicine Diagnostic Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET DYNAMICS
3.1. Nuclear Medicine Diagnostic Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising number of new cancer cases
3.1.1.2. Increasing adoption of SPECT and PET modality
3.1.2. Market Challenges
3.1.2.1. Stringent government regulations
3.1.3. Market Opportunities
3.1.3.1. Innovations in neurological applications
CHAPTER 4. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY TYPE
5.1. Market Snapshot
5.2. Global Nuclear Medicine Diagnostic Market by Type, Performance - Potential Analysis
5.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
5.4.1. SPECT radiopharmaceuticals
5.4.2. PET radiopharmaceuticals
CHAPTER 6. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY MODALITY
6.1. Market Snapshot
6.2. Global Nuclear Medicine Diagnostic Market by Modality, Performance - Potential Analysis
6.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Modality 2018-2027 (USD Billion)
6.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
6.4.1. SPECT
6.4.2. PET
6.4.3. Alpha-emitters
6.4.4. Beta-emitters
6.4.5. Brachytherapy
CHAPTER 7. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Nuclear Medicine Diagnostic Market by Application, Performance - Potential Analysis
7.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
7.4.1. Cardiology
7.4.2. Thyroid
7.4.3. Neurology
7.4.4. Oncology
7.4.5. Others
CHAPTER 8. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY PROCEDURE:
8.1. Market Snapshot
8.2. Global Nuclear Medicine Diagnostic Market by Procedure, Performance - Potential Analysis
8.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Procedure 2018-2027 (USD Billion)
8.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
8.4.1. Oncology
8.4.2. Cardiovascular
8.4.3. Central Nervous System
8.4.4. Endocrine
8.4.5. Skeletal
8.4.6. Gastrointestinal
8.4.7. Genito-urinary
8.4.8. Pulmonary
8.4.9. PET & PET-CT
8.4.10. Therapeutics
8.4.11. Others
CHAPTER 9. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, BY END-USER:
9.1. Market Snapshot
9.2. Global Nuclear Medicine Diagnostic Market by End-User, Performance - Potential Analysis
9.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
9.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
9.4.1. Hospitals and diagnostic centres
9.4.2. Research Institutes
CHAPTER 10. GLOBAL NUCLEAR MEDICINE DIAGNOSTIC MARKET, REGIONAL ANALYSIS
10.1. Nuclear Medicine Diagnostic Market, Regional Market Snapshot
10.2. North America Nuclear Medicine Diagnostic Market
10.2.1. U.S. Nuclear Medicine Diagnostic Market
10.2.1.1. Type breakdown estimates & forecasts, 2018-2027
10.2.1.2. Modality breakdown estimates & forecasts, 2018-2027
10.2.1.3. Application breakdown estimates & forecasts, 2018-2027
10.2.2. Canada Nuclear Medicine Diagnostic Market
10.3. Europe Nuclear Medicine Diagnostic Market Snapshot
10.3.1. U.K. Nuclear Medicine Diagnostic Market
10.3.2. Germany Nuclear Medicine Diagnostic Market
10.3.3. France Nuclear Medicine Diagnostic Market
10.3.4. Spain Nuclear Medicine Diagnostic Market
10.3.5. Italy Nuclear Medicine Diagnostic Market
10.3.6. Rest of Europe Nuclear Medicine Diagnostic Market
10.4. Asia-Pacific Nuclear Medicine Diagnostic Market Snapshot
10.4.1. China Nuclear Medicine Diagnostic Market
10.4.2. India Nuclear Medicine Diagnostic Market
10.4.3. Japan Nuclear Medicine Diagnostic Market
10.4.4. Australia Nuclear Medicine Diagnostic Market
10.4.5. South Korea Nuclear Medicine Diagnostic Market
10.4.6. Rest of Asia Pacific Nuclear Medicine Diagnostic Market
10.5. Latin America Nuclear Medicine Diagnostic Market Snapshot
10.5.1. Brazil Nuclear Medicine Diagnostic Market
10.5.2. Mexico Nuclear Medicine Diagnostic Market
10.6. Rest of The World Nuclear Medicine Diagnostic Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. AMCS group
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Caverion corporation
11.2.3. Aerbin ApS
11.2.4. MariMatic Oy
11.2.5. Envac Group
11.2.6. Logiwaste AB
11.2.7. AWC Berhad Gropu
11.2.8. Ros Roca SA
11.2.9. Greenwave Solutions
11.2.10. STREAM environment
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Nuclear Medicine Diagnostic market, report scope
TABLE 2. Global Nuclear Medicine Diagnostic market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Nuclear Medicine Diagnostic market estimates & forecasts by Type 2018-2027 (USD Billion)
TABLE 4. Global Nuclear Medicine Diagnostic market estimates & forecasts by Modality 2018-2027 (USD Billion)
TABLE 5. Global Nuclear Medicine Diagnostic market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 6. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Nuclear Medicine Diagnostic market
TABLE 56. List of primary sources, used in the study of global Nuclear Medicine Diagnostic market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
TABLE 1. Global Nuclear Medicine Diagnostic market, report scope
TABLE 2. Global Nuclear Medicine Diagnostic market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Nuclear Medicine Diagnostic market estimates & forecasts by Type 2018-2027 (USD Billion)
TABLE 4. Global Nuclear Medicine Diagnostic market estimates & forecasts by Modality 2018-2027 (USD Billion)
TABLE 5. Global Nuclear Medicine Diagnostic market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 6. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Nuclear Medicine Diagnostic market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Nuclear Medicine Diagnostic market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Nuclear Medicine Diagnostic market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Nuclear Medicine Diagnostic market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Nuclear Medicine Diagnostic market
TABLE 56. List of primary sources, used in the study of global Nuclear Medicine Diagnostic market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Nuclear Medicine Diagnostic market, research methodology
FIG 2. Global Nuclear Medicine Diagnostic market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Nuclear Medicine Diagnostic market, key trends 2020
FIG 5. Global Nuclear Medicine Diagnostic market, growth prospects 2021-2027
FIG 6. Global Nuclear Medicine Diagnostic market, porters 5 force model
FIG 7. Global Nuclear Medicine Diagnostic market, pest analysis
FIG 8. Global Nuclear Medicine Diagnostic market, value chain analysis
FIG 9. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Nuclear Medicine Diagnostic market, regional snapshot 2018 & 2027
FIG 15. North America Nuclear Medicine Diagnostic market 2018 & 2027 (USD Billion)
FIG 16. Europe Nuclear Medicine Diagnostic market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Nuclear Medicine Diagnostic market 2018 & 2027 (USD Billion)
FIG 18. Latin America Nuclear Medicine Diagnostic market 2018 & 2027 (USD Billion)
FIG 19. Global Nuclear Medicine Diagnostic market, company market share analysis (2020)
FIG 1. Global Nuclear Medicine Diagnostic market, research methodology
FIG 2. Global Nuclear Medicine Diagnostic market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Nuclear Medicine Diagnostic market, key trends 2020
FIG 5. Global Nuclear Medicine Diagnostic market, growth prospects 2021-2027
FIG 6. Global Nuclear Medicine Diagnostic market, porters 5 force model
FIG 7. Global Nuclear Medicine Diagnostic market, pest analysis
FIG 8. Global Nuclear Medicine Diagnostic market, value chain analysis
FIG 9. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Nuclear Medicine Diagnostic market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Nuclear Medicine Diagnostic market, regional snapshot 2018 & 2027
FIG 15. North America Nuclear Medicine Diagnostic market 2018 & 2027 (USD Billion)
FIG 16. Europe Nuclear Medicine Diagnostic market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Nuclear Medicine Diagnostic market 2018 & 2027 (USD Billion)
FIG 18. Latin America Nuclear Medicine Diagnostic market 2018 & 2027 (USD Billion)
FIG 19. Global Nuclear Medicine Diagnostic market, company market share analysis (2020)
